Investors Relations

News & Disclosure

News
Disclosure

Ibnsina Pharma Welcomes Dr.Sahar Nasr Former Investment and International Cooperation Minister as Independent Board Member

2024 03 Mar

Ibnsina Pharma is at the forefront of drug distribution companies.

2023 17 Jul

Ibnsina Pharma Signed Three Medical Promotion Contracts For the First Time

2023 14 Jun

Ibnsina Pharma Issues First Sustainability Report

2023 05 Jun

Boehringer Ingelheim and Ibnsina Pharma Sign Distribution Agreement in Egypt

2023 05 Feb

Ibnsina Pharma and Sandoz Egypt Pharma ink strategic partnership to improve patient access to OTC Products

2023 29 Jan

Ibnsina Pharma and OMRON Healthcare sign an importation & distribution agreement in Egypt

2022 23 Oct

Ibnsina Pharma Taps Into the Hospital Business With the Acquisition of El Shorouk Hospital at El Shorouk City

2022 23 May

Ibnsina Pharma Turns to Solar Power for Sustainable and Affordable Energy

2022 20 Jan

Disclosure to EGX regarding Ibnsina BOD Meeting

2023 15 Nov

Ibnsina Pharma Disclosure Form for the BoD & the Shareholders’ Structure

2023 27 Sep

Ibnsina Pharma Organization Structure and Data Modification Form

2023 27 Sep

Release from Ibnsina Pharma (ISPH.CA)

2020 14 Dec

Ibnsina Pharma (ISPH.CA) – Disclosure Form for the BoD & the Shareholders’ Structure

2019 14 Jan

Release from Ibnsina Pharma (ISPH.CA)

2019 13 Jan